Psilocybin Laws in Minnesota
Minnesota has active psilocybin reform legislation and has been among the more progressive midwestern states on drug policy. Minnesota legalized recreational cannabis in 2023 and psilocybin bills have advanced in the legislature.
Current Legal Status
Active Legislation
Psilocybin remains a Schedule I controlled substance under Minnesota law. A bill to establish a psilocybin therapeutic access program passed the Minnesota House in 2025 and is awaiting Senate action.
Key Legislation
HF 2908 (2024) proposed a licensed psilocybin therapy program — passed House Health Committee. HF 1014 (2025) revised version passed the full House; Senate companion bill SF 982 is in committee. **March 2026:** a bipartisan psilocybin pilot program bill advanced through its first committee with both Republican and DFL sponsors — a meaningful broadening of Minnesota's reform coalition. Minneapolis remains under city-level deprioritization for personal possession.
Clinical Trials
University of Minnesota has broad pharmacology research programs. Check ClinicalTrials.gov for Minneapolis–St. Paul area enrolling psilocybin studies.
Advocacy Organizations
Minnesota Psilocybin Alliance, Healing Advocacy Fund, Minnesota Veterans for Natural Medicine.
Related Resources
People in Minnesota
- Dr. Jessica Nielson — Founder, Psychedelic Society of Minnesota; Chair, MN Psychedelic Medicine Task Force
- Dennis McKenna, Ph.D. — Ethnopharmacologist; Author; Founder, McKenna Academy
Societies & Organizations in Minnesota
- Psychedelic Society of Minnesota — Community Society
- Psychedelic Society of Minneapolis — Community Group
See how Minnesota compares to neighboring states and find therapy options for residents: